Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp Under 10b5-1 Trading Plan
SEC Form 4
The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between July 3rd and July 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Carlyle Group, a major shareholder of QuidelOrtho Corp (QDEL), has reported the sale of QDEL common stock.
- The sales occurred on July 3rd and July 5th, 2024.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2024.
- On July 3rd, 46,391 shares were sold at a weighted average price of $30.8379, with individual prices ranging from $30.6163 to $30.9999.
- An additional 6,333 shares were sold on July 3rd at a weighted average price of $31.0816, with prices ranging from $31.00 to $31.40.
- On July 5th, 6,406 shares were sold at a weighted average price of $30.8503, with prices ranging from $30.6299 to $30.9996.
- Finally, on July 5th, 44,333 shares were sold at a weighted average price of $31.1957, with prices ranging from $31.0036 to $31.36.
- Following these transactions, Carlyle Group's indirect beneficial ownership stands at 11,249,724 shares.
- The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
- Carlyle Group Inc. disclaims beneficial ownership of these securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing reporting share sales. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about transactions.
Industry Context
This filing indicates activity by a major shareholder, which is common in the financial markets. Monitoring such transactions can provide insights into investor sentiment and potential future stock performance.
Stakeholder Impact
- Shareholders may react to the news of Carlyle Group selling shares, potentially impacting the stock price.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely minimal, as this is a financial transaction by a major shareholder.
Key Dates
| Date | Description |
|---|---|
| May 12, 2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| July 03, 2024 | Date of first reported transaction (share sales). |
| July 05, 2024 | Date of second reported transaction (share sales). |
| July 08, 2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.